Journey Medical (DERM) Total Current Liabilities (2020 - 2026)

Journey Medical has reported Total Current Liabilities for 7 years, with the latest figure at $37.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 5.95% year-over-year to $37.8 million; the trailing twelve-month figure through Mar 2026 stood at $37.8 million (down 5.95% YoY), and the FY2025 full-year result was $37.4 million, up 6.44% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $37.8 million, up from $37.4 million in the prior quarter.
• The five-year high for Total Current Liabilities was $76.9 million in Q1 2023, with the low at $33.3 million in Q3 2024.
• Historically, Total Current Liabilities has averaged $48.3 million across 5 years, with a median of $40.5 million in 2025.
• Annual changes were most pronounced in 2022 — Total Current Liabilities gained 29.48% — and 2024, when it sank 49.93%.
• Journey Medical's Total Current Liabilities stood at $66.8 million in 2022, then slumped by 37.35% to $41.9 million in 2023, then dropped by 15.99% to $35.2 million in 2024, then rose by 6.44% to $37.4 million in 2025, then advanced by 1.04% to $37.8 million in 2026.
• The last three Total Current Liabilities figures came in at $37.8 million (Q1 2026), $37.4 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.